Package 82804-118-60

{"route": ["ORAL"], "spl_id": "c7ed8234-e6bd-4f19-a1ce-40f272a79036", "openfda": {"nui": ["N0000175427", "N0000190114", "N0000185503", "N0000182137", "N0000187061"], "upc": ["0382804118601"], "unii": ["A6IEZ5M406"], "rxcui": ["616749"], "spl_set_id": ["c7ed8234-e6bd-4f19-a1ce-40f272a79036"], "pharm_class_epc": ["Anti-anginal [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "manufacturer_name": ["Proficient Rx LP"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (82804-118-60)", "package_ndc": "82804-118-60", "marketing_start_date": "20240705"}], "brand_name": "Ranolazine", "product_id": "82804-118_c7ed8234-e6bd-4f19-a1ce-40f272a79036", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Anti-anginal [EPC]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Organic Cation Transporter 2 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "82804-118", "generic_name": "Ranolazine", "labeler_name": "Proficient Rx LP", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ranolazine", "active_ingredients": [{"name": "RANOLAZINE", "strength": "500 mg/1"}], "application_number": "ANDA211829", "marketing_category": "ANDA", "marketing_start_date": "20210824", "listing_expiration_date": "20261231"}